LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Correlation of Serum Alpha-Fetoprotein (AFP) Levels with the size of Hepatocellular carcinoma on Triphasic CT scan

    Javeria Khan / Maria Khaliq / Tayyub Saeed / Muhammad Imran / Nasir Majeed / Rabia Khan / Muhammad Umar / Bushra Khaar / Tanveer Hussain / Sadia Ahmed / Misbah Noureen / Saima Ambreen

    Journal of Rawalpindi Medical College, Vol 1, Iss

    A study in patients with the heterotrophic viral infection

    2022  Volume 1

    Abstract: Objective: To determine the association between serum Alpha-Fetoprotein (AFP) levels with different variables including Hepatocellular tumor size. Materials and Methods: This cross-sectional study was conducted in the Center of Liver and Digestive ... ...

    Abstract Objective: To determine the association between serum Alpha-Fetoprotein (AFP) levels with different variables including Hepatocellular tumor size. Materials and Methods: This cross-sectional study was conducted in the Center of Liver and Digestive Diseases, Holy Family Hospital, Rawalpindi. Three hundred and thirty-four liver cirrhosis patients complicated with HCC were participants. Different variables such as diabetes, hypertension, ischemic heart disease, smoking, jaundice, fever, lethargy, weight loss, anorexia, pain right hypochondrium, abdominal distention, ascites, encephalopathy, biochemical tests (Bilirubin levels, serum albumin levels, prothrombin time(PT) (<4 /4-6 / >6 sec prolonged), child Turcotte class ( A, Band C), PST(performance status), Barcelona Clinic liver cancer staging system (0/A/B/C/D) and tumor size in 3 Groups (Group I size <3 cm, Group II size 3-5cm, and Group size III >5cm size) were compared with serum Alpha Feto Proteins (AFP) levels( Group I AFP level >20 and <200ng/mL, Group II AFP level 200-400 ng/mL, while Group III AFP level was >400ng/mL). Data were analyzed through SPSS Statistics version 23.0 (IBM, Armonk, NY), Spearman’s rank is used for P-value. Results: The AFP (Group-I/II/III )association with diabetes (P 0.121), HTN (P 0.811), IHD (P 0.546), HBsAg positive patients (all P 0.186), HCV positive patients (all P 0.131), pain right hypochondrium (P 0.599), fever (P 0.065), lethargy (P 0.388) and Encephalopathy (all P 0.075) were identified as non-significant association while biochemical levels such as Bilirubin (P 0.000), Albumin (P 0.000), Prothrombin Time (P 0.038) creatinine ( all P 0.001) , Child Turcotte Class A, B and C (P 0.000),smoking (P 0.023), weight Loss (P 0.002), Anorexia (P 0.007), Jaundice (P 0.012), Ascites (P value 0.000), ECOG (P 0.000), Barcelona Clinic for liver cancer (BCLC) staging system (P 0.000), lesion I (P 0.000) and lesions II (P 0.006) on CECT had significant association. Conclusion: We hereby, conclude that there is a ...
    Keywords Serum Alpha-Fetoprotein (AFP) Levels ; hepatocellular carcinoma ; heterotrophic viral infection ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2022-06-01T00:00:00Z
    Publisher Rawalpindi Medical University
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Safety data in randomised real-world evidence studies

    Catherine Harvey / Ashley Woodcock / Jørgen Vestbo / Courtney Crim / Lucy Frith / Nawar Diar Bakerly / John P. New / Claire Williams / Hanaa Elkhenini / Nasir Majeed / Glenn Cardwell / Susan Collier / Loretta Jacques / Joanne Fletcher

    ERJ Open Research, Vol 7, Iss

    Salford Lung Study learnings

    2021  Volume 2

    Abstract: Evidence to support clinical decision making must be based on safety data that have been captured, analysed and interpreted in a robust and reliable way. Randomised real-world evidence (RRWE) studies provide the opportunity to evaluate the use of ... ...

    Abstract Evidence to support clinical decision making must be based on safety data that have been captured, analysed and interpreted in a robust and reliable way. Randomised real-world evidence (RRWE) studies provide the opportunity to evaluate the use of medicines in patients and settings representative of routine clinical practice. However, elements that underpin the design of RRWE studies can have a significant impact upon the analysis, interpretation and implications of safety data. In this narrative review, we use data from the Salford Lung Study; two prospective, 12-month, open-label, parallel-group, phase III randomised controlled trials conducted in primary care in the UK; to highlight the importance of capturing treatment modifications when attempting to evaluate safety events according to actual treatment exposure. We demonstrate that analysing safety data by actual treatment received (i.e. accounting for the treatment modifications that occur routinely in the primary care setting) provides additional insight beyond analysing according to randomised treatment strategy only. It is therefore proposed that understanding of safety data from RRWE trials can be optimised by analysing both by randomised group and by actual treatment received.
    Keywords Medicine ; R
    Subject code 610
    Language English
    Publishing date 2021-05-01T00:00:00Z
    Publisher European Respiratory Society
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top